References
- LeblondAAllanoreYAvouacJTargeting synovial neoangiogenesis in rheumatoid arthritisAutoimmun Rev20171659460128414154
- MostmansYCutoloMGiddeloCThe role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic reviewAutoimmun Rev201716877478628572048
- MaruottiNCantatoreFPNicoBVaccaARibattiDAngiogenesis in vasculitidesClin Exp Rheumatol20082647648318578974
- ElshabrawyHAChenZVolinMVRavellaSVirupannavarSShahraraSThe pathogenic role of angiogenesis in rheumatoid arthritisAngiogenesis20151843344826198292
- YamamotoTAngiogenic and inflammatory properties of psoriatic arthritisISRN Dermatol2013201363062023819059
- RisauWMechanisms of angiogenesisNature19973866716749109485
- PepperMSManipulating angiogenesis: from basic science to the bedsideArterioscler Thromb Vasc Biol1997176056199108772
- MaruottiNCantatoreFPCrivellatoEVaccaARibattiDAngiogenesis in rheumatoid arthritisHistol Histopathol20062155756616493585
- CantatoreFPMaruottiNCorradoARibattiDAngiogenesis dysregulation in psoriatic arthritis: molecular mechanismsBiomed Res Int20172017531281328804717
- ReeceRJCaneteJDParsonsWJEmeryPVealeDJDistinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritisArthritis Rheum1999421481148410403277
- SzekaneczZKochAEMechanism of disease: angiogenesis in inflammatory diseasesNat Clin Pract Rheumatol2007363564317968334
- BodolayEKochAEKimJSzegediGSzekaneczZAngiogenesis and chemokines in rheumatoid arthritis and other sistemi inflammatory rheumatic diseasesJ Cell Mol Med2002635737612417052
- ZhouLLuGShenLWangLWangMSerum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significanteBiomed Res Int2014201462712624511540
- WestphalJRBoerboomsAMTSchalkwijkCJMAnti-endothelial cell antibodies in sera of patients with autoimmune diseases: comparison between ELISA and FACS analysisClin Exp Immunol1994964444498004814
- GiraudoEPrimoLAuderoETumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cellsJ Biol Chem199827322128221359705358
- Fernández-VegaBFernández-VegaÁRangelCMBlockade of tumor necrosis factor-alpha: a role for adalimumab in neovascular age-related macular degeneration refractory to anti-angiogenesis therapy?Case Rep Ophthalmol2016715416227065854
- KimJWChungSKThe effect of topical infliximab on corneal neo-vascularization in rabbitsCornea20133218519023146933
- FerrariGBignamiFRamaPTumor necrosis factor-α inhibitors as a treatment of corneal hemangiogenesis and lymphangiogenesisEye Contact Lens201541727625503908
- VoiculescuOBVoineaLMInfliximab eye drops treatment in corneal neovascularizationJ Med Life2015856656726664491
- CampanatiAOrcianiMGanzettiGConsalesVDi PrimioROffidaniAThe effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasisJ Int Med Res2016441 Suppl6927683131
- LaiKCLiuCJLinTJBlocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cellsCancer Lett201637020721526515391
- ShuQAminMARuthJHCampbellPLKochAESuppression of endothelial cell activity by inhibition of TNFαArthritis Res Ther201214R8822534470
- AltorjayIVerébZSerfozoZAnti-TNF-alpha antibody (infliximab) therapy supports the recovery of eNOS and VEGFR2 protein expression in endothelial cellsInt J Immunopathol Pharmacol20112432333521658307
- EderPLykowska-SzuberLIwanikKThe influence of anti-TNF therapy on CD31 and VEGF expression in colonic mucosa of Crohn’s disease patients in relation to mucosal healingFolia Histochem Cyto-biol2016547580
- LiuYYangGZhangJAnti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis”Int Immunopharmacol20152873174326263167
- PaleologEMAngiogenesis: a critical process in the pathogenesis of RA – a role of VEGF?Br J Rheumatol1996359179198883427
- AfuwapeAOKiriakidisSPaleologEMThe role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritisHistol Histopathol20021796197212168808
- NagashimaMYoshinoSIshiwataTAsanoGRole of vascular endothelial growth factor in angiogenesis of rheumatoid arthritisJ Rheumatol199522162416308523334
- BallaraSTaylorPCReuschPRaised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritisArthritis Rheum2001442055206411592367
- KasamaTShiozawaFKobayashiKVascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritisArthritis Rheum2001442512252411710707
- HaradaMMitsuyamaKYoshidaHVascular endothelial growth factor in patients with rheumatoid arthritisScand J Rheumatol1998273773809808403
- WaukeKNagashimaMIshiwataTAsanoGYoshinoSExpression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissueJ Rheumatol200229343811824968
- PaleologEMYoungSStarkACMcCloskeyRVFeldmannMMainiRModulation of angiogenic vascular endothelial growth factor by tumor necrosis factor a and interleukin-1 in rheumatoid arthritisArthritis Rheum199841125812659663484
- StrunkJBundkeELangeUAnti-TNF-alpha antibody infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot studyRheumatol Int20062625225615999273
- MastroianniAMinutilliEMussiACytokine profiles during infliximab monotherapy in psoriatic arthritisBr J Dermatol200515353153616120138
- Cordiali-FeiPTrentoED’AgostoGEffective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesionsAnn N Y Acad Sci2007111057858917911474
- GoedkoopAYKraanMCPicavetDIDeactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre studyArthritis Res Ther20046R326R33415225368
- IzquierdoECañeteJDCelisRImmature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapyPLoS One20094e813119956574
- ShinrikiSJonoHOtaKHumanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinomaClin Cancer Res2009155426543419706815
- HirohataSAbeAMurasawaAKanamonoTTomitaTYoshikawaHDifferential effects of IL-6 blockade tocilizumab and TNF inhibitors on angiogenesis in synovial tissues from patients with rheumatoid arthritisMod Rheumatol20161517
- Herrero-BeaumontGMartínez CalatravaMJCastañedaSAbatacept mechanism of action: concordance with its clinical profileReumatol Clin20128788322104048
- ParadisTJFloydEBurkwitJThe anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFN gammaCancer Immunol Immunother20015012513311419179
- CutoloMMontagnaPSoldanoSCTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expressionClin Exp Rheumatol20153325025425896473
- UmemuraMIsozakiTIshiiSReduction of serum ADAM17 level accompanied with decreased cytokines after abatacept therapy in patients with rheumatoid arthritisInt J Biomed Sci20141022923525598752
- PatelIRAtturMGPatelRNTNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alphaJ Immunol1998160457045799574564
- OhtaSHarigaiMTanakaMTumor necrosis factor-alpha (TNF-alpha) converting enzyme contributes to production of TNF-alpha in synovial tissues from patients with rheumatoid arthritisJ Rheumatol2001281756176311508576
- CharbonneauMHarperKGrondinFPelmusMMcDonaldPPDuboisCMHypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cellsJ Biol Chem2007282337143372417884817
- BlackRARauchCTKozloskyCJA metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cellsNature19973857297339034190
- MossMLJinSLMillaMECloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alphaNature19973857337369034191
- GartonKJGoughPJBlobelCPTumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)J Biol Chem2001276379933800111495925
- PeschonJJSlackJLReddyPAn essential role for ectodomain shedding in mammalian developmentScience1998282128112849812885
- AlthoffKReddyPVoltzNRose-JohnSMüllbergJShedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteinsEur J Biochem20002672624263110785383
- MonachPATomassonGSpecksUCirculating markers of vascular injury and angiogenesis in antineutrophilcytoplasmic antibody-associated vasculitisArthritis Rheum2011633988399721953143
- PowellJRDojcinovSKingLPrognostic significance of hypoxia inducible factor-1α and vascular endothelial growth factor expression in patients with diffuse large B-cell lymphoma treated with rituximabLeuk Lymphoma20135495996623020605
- Ben-AvPCroffordLJWilderRLHlaTInduction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesisFEBS Lett199537283877556649
- ElarajDMWeinreichDMVargheseSThe role of interleukin 1 in growth and metastasis of human cancer xenograftsClin Cancer Res2006121088109616489061
- CarboneCTamburrinoAPiroGCombined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatmentAnticancer Drugs201627294026473526
- CoxonABolonBEstradaJInhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritisArthritis Rheum2002462604261212384918
- OlsonJLCourtneyRJRouhaniBMandavaNDinarelloCAIntravitreal anakinra inhibits choroidal neovascular membrane growth in a rat modelOcul Immunol Inflamm200917319520019585363